unknown
Stage
1
Investors
About
HYKU Biosciences is a biotechnology company listed in the Novartis Venture Fund portfolio. Novartis Venture Fund lists it among biotechnology and biopharma life-science companies developing therapeutics and platform technologies.
Explore HYKU Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.